Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A EBIT

The latest EBIT for BDXA is $2.5B as of September 2026. That compares with $2.5B in the prior-year period — down 1.9% year over year. That is below the Healthcare sector average of $99B. Investors often review this figure alongside Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A's historical trend and sector peers before judging valuation or financial health.

Over the past year, BDXA's EBIT moved from $2.5B to $2.5B — a 1.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A's operating scale or balance-sheet position.

Against Healthcare companies, BDXA currently prints $2.5B for EBIT, while the sector average sits near $99B. That is roughly 97.5% below the sector mean. Large gaps often invite a closer look at Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A's growth, margins, and balance sheet.

A EBIT figure of $2.5B for BDXA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $99B. Explore the charts below for those layers of context.

After noting BDXA's EBIT ($2.5B), review year-over-year change from $2.5B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.